LIZ LAGUERRE: Open Payments
NPI 1891243283 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,143 in 97 payments from 29 companies in 2025. Trend: 2023 $273 · 2024 $563 · 2025 $2,143
Food & beverage: $2,143
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $546 |
| UCB, Inc. | 8 | $193 |
| ACADIA Pharmaceuticals Inc | 4 | $174 |
| Grifols USA, LLC | 5 | $130 |
| Genentech USA, Inc. | 4 | $107 |
| EMD Serono, Inc. | 1 | $105 |
| Biogen, Inc. | 4 | $94 |
| JAZZ PHARMACEUTICALS INC. | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Lundbeck LLC | 4 | $72 |
Products named: QULIPTA, UBRELVY, NUPLAZID, BOTOX, Gamunex-C, Ocrevus Zunovo, Mavenclad, Fintepla.
Industry payments across FL — which companies pay providers there.
